Effects of aldosterone on Cx43 gap junction expression in neonatal rat cultured cardiomyocytes

Circulation Journal

Volumn 73, Issue 8, 2009, Pages 1504-1512

  Suzuki, Shinsuke ^a   Ohkusa, Tomoko ^a   Sato, Takashi ^a   Yoshida, Masaaki ^a   Yasui, Kenji ^b   Miwa, Keiko ^b   Lee, Jong Kook ^b   Yano, Masafumi ^a   Kodama, Itsuo ^b   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Aldosterone; Connexin43; Gap junction; Mineralocorticoid receptor; Mitogen activated protein kinases (MAPKs)

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CHELERYTHRINE; CONNEXIN 43; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; EPLERENONE; GAP JUNCTION PROTEIN; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LOSARTAN; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CELL JUNCTION; CELL STRUCTURE; ELECTRODE; GAP JUNCTION; HEART ARRHYTHMIA; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALDOSTERONE; ANIMALS; ANIMALS, NEWBORN; ARRHYTHMIAS, CARDIAC; CELLS, CULTURED; CONNEXIN 43; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; GAP JUNCTIONS; GENE EXPRESSION REGULATION; MYOCYTES, CARDIAC; RATS; RNA, MESSENGER;

EID: 69049107752     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1065     Document Type: Article

References (49)

1. Bonvalet JP. Regulation of sodium transport by steroid hormones. Kidney Int 1998; 65: S49-S56. (Pubitemid 28204565)
2. Knox JR, Lockett MF. Similarity between a substrate produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone. J Endocrinol 1969; 43: 315-316.
3. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat: Physiological regulation. J Biol Chem 1998; 273: 4883-4891. (Pubitemid 28108638)
4. Funder JW. Glucocorticoid and mineralocorticoid receptors: Biology and clinical relevance. Annu Rev Med 1997; 48: 231-240.
5. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996; 28: 781-787. (Pubitemid 126334811)
6. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355-1364.
7. Robert V, Nguyen VT, Cheav SL, Mouas C, Swynghedauw B, Delcayre C. Increased cardiac types I and II collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994; 24: 30-36. (Pubitemid 24195401)
8. Campbell SE, Janicki JS, Mastubara BB, Weber KT. Myocardial fibrosis in the rat with mineralocorticoid excess: Prevention of scaring by amiloride. Am J Hypertens 1993; 6: 487-495.
9. Duprez DA, Bauwens FR, De Buyzere ML, De Backer TL, Kaufman JM, Van Hoecke J, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993; 71: 17A-20A. (Pubitemid 23046407)
10. Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, et al. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 2003; 93: 69-76.
11. Silvestre JS, Heymes C, Oubénaïssa A, Robert V, Aupetit-Faisant B, Carayon A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999; 99: 2694-2701. (Pubitemid 29237459)
12. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-77. (Pubitemid 32050438)
13. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
14. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.
15. Arora RB, Somari P. Ectopic arrhythmia provoking action of aldosterone. Life Sci 1962; 5: 215-218.
16. +-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol Chem 1991; 266: 12058-12066. (Pubitemid 21907057)
17. + pump activation during short-term exposure of cardiac myocytes to aldosterone. Am J Physiol 1998; 274: C175-C181. (Pubitemid 28099357)
18. 2+ current in mice. J Physiol 2005; 569: 153-162. (Pubitemid 41701382)
19. Sayers G, Lefer AM, Nadzam GR. Aldosterone and cardiac function. Endocrinology 1966; 78: 211-213.
20. Boixel C, Gavillet B, Rouqier JS, Abriel H. Aldosterone increases voltage-gated sodium current in ventricular myocytes. Am J Physiol 2006; 290: H2257-H2266. (Pubitemid 43846052)
21. Lalevée N, Rebsamen MC, Barrère-Lemaire S, Perrier E, Nargeot J, Bénitah JP, et al. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. Cardiovasc Res 2005; 67: 216-224.
22. Muto T, Ueda N, Opthof T, Ohkusa T, Nagata K Suzuki S, et al. Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2007; 293: H2710-H2718. (Pubitemid 350106494)
23. Ouvrard-Pascaud A, Sainte-Marie Y, Bénitah JP, Perrier R, Soukaseum C, Cat AN, et al. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 2005; 111: 3025-3033. (Pubitemid 40847778)
24. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004; 95: 1035-1041. (Pubitemid 39532334)
25. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res 2000; 86: 1193-1197.
26. Saffitz JE, Laing JG, Yamada KA. Connexin expression and turnover: Implications for cardiac excitability. Circ Res 2000; 86: 723-728.
27. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004; 62: 368-377. (Pubitemid 38496549)
28. Inoue N, Ohkusa T, Nao T, Lee JK, Matsumoto T, Hisamatsu Y, et al. Rapid electrical stimulation of contraction modulates gap junction protein in neonatal rat cultured cardiomyocytes: Involvement of mitogen-activated protein kinases and effects of angiotensin II-receptor antagonist. J Am Coll Cardiol 2004; 44: 914-922. (Pubitemid 39099593)
29. Yamamoto M, Yoshimura M, Nakayama M, Abe K, Sumida H, Sugiyama S, et al. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes. Circ J 2008; 72: 1346-1350.
30. Salameh A, Frenzel C, Boldt A, Rassler B, Glawe I, Schulte J, et al. Subcbronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J 2006; 20: 365-367. (Pubitemid 46671173)
31. Doble BW, Ping P, Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 2000; 86: 293-301. (Pubitemid 30108823)
32. Yamamuro M, Yoshimura M, Nakayama M, Abe K, Shono M, Suzuki S, et al. Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extracellular sodium. Endocrinology 2006; 147: 1314-1321. (Pubitemid 43244365)
33. Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, et al. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 2005; 16: 878-891. (Pubitemid 41710298)
34. Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, Tateno T, et al. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 2005; 146: 3900-3906. (Pubitemid 41175760)
35. 2+ channel in murine hearts during the embryonic period. Am J Physiol 2004; 286: H2257-H2263. (Pubitemid 38685241)
36. Zhuang J, Yamada KA, Saffitz JE, Kleber AG. Pulsatile stretch remodels cell-to-cell communication in cultured myocytes. Circ Res 2000; 87: 316-322. (Pubitemid 30655973)
37. Oka H, Shimono K, Ogawa R, Sugihara H, Taketani M. A new planar multielectrode array for extracellular recording: Application to hippocampal acute slice. J Neurosci Methods 1999; 93: 61-67. (Pubitemid 29516627)
38. Shimono K, Brucher F, Granger R, Lynch G, Taketani M. Origins and distribution of cholinergically induced beta rhythms in hippocampal slices. J Neurosci 2000; 20: 8462-8473.
39. Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, et al. Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 2004; 110: 317-323. (Pubitemid 38955501)
40. Farman N, Rafestin-Oblin ME. Multiple aspects of mineralocorticoid selectivity. Am J Physiol 2001; 280: F181-F192.
41. Funder JW. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 1993; 259: 1132-1133. (Pubitemid 23085350)
42. Wei Y, Dahl G, Werner R. The connexin43 gene is responsive to oestrogen. Proc R Soc Land B 1994; 255: 125-132.
43. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, O'Connell TD, et al. Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 2004; 10: 511-518. (Pubitemid 39626781)
44. Polontchouk L, Ebelt B, Jackels M, Dhein S. Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 2002; 16: 87-89.
45. Funder JW. The nongenomic actions of aldosterone. Endocr Rev 2005; 26: 313-321.
46. Sheppard KE, Autelitano DJ. 11β-Hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorucosterone into transcriptionally active glucocorticoid in neonatal rat heart. Endocrinology 2002; 143: 198-204.
47. Rousseau MF, Gurné O, Duprez D, Van Mieghem W, Robert A, Ahn S, et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: Results from the RALES neurohormonal substudy. J Am Coll Cardiol 2002; 40: 1596-1601. (Pubitemid 35253637)
48. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999; 42: 270-283. (Pubitemid 29243156)
49. Bian W, Tung L. Structure-related initiation of reentry by rapid pacing in monolayers of cardiac cells. Circ Res 2006; 98: 29-38. (Pubitemid 43755317)